PBS listing to help prevent invasive fungal infections
The Department of Health and Ageing says thousands of patients suffering from invasive fungal infections will benefit from a new listing on the Pharmaceutical Benefits Scheme (PBS) from 1 January 2009.
Posaconazole (Noxafil) has been subsidised for patients using the medication for the prevention and treatment of invasive fungal infections.
From 1 January 2009, ibandronic acid 50 mg tablets (Bondronat) will be listed on the PBS to broaden the treatment options available to patients with bone metastases (bone secondary cancer) from breast cancer.
There are no expected cost implications for the PBS as a result of this listing, as this medicine will serve existing patients.
